Registered entities
RENEO PHARMACEUTICALS, INC.
Reg. No. 47-2309515United States
Innovation
6 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 520 times.
| Year | Filings |
|---|---|
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 4 |
Investor mix
10 investors on record; lead investors include New Enterprise Associates, Novo Holdings, Abingworth; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 70% |
| Private equity | 2 | 20% |
| Other / undisclosed | 1 | 10% |